Plasma Binding of Imipramine and Clinical Outcome

Brinkschulte M, Gaertner H, Schied H, Breyer-Pfaff U Eur J Clin Pharmacol. 1982; 22(4):367-73.

PMID: 6125396 DOI: 10.1007/BF00548407.

Pollock B, Perel J Can Med Assoc J. 1984; 131(7):717.

PMID: 6089988 PMC: 1483591.

R Sallee F, Pollock B Clin Pharmacokinet. 1990; 18(5):346-64.

PMID: 2185906 DOI: 10.2165/00003088-199018050-00002.

Asbach H, Mohring K, Holz F, SCHULER H, Herrmann B, Faigle J Klin Wochenschr. 1976; 54(2):83-7.

PMID: 1249904 DOI: 10.1007/BF01468773.

Kragh-Sorensen P, Hansen C, BAASTRUP P, Hvidberg E Psychopharmacologia. 1976; 45(3):305-12.

PMID: 766041 DOI: 10.1007/BF00421145.

Hughes I Br J Pharmacol. 1978; 63(2):315-21.

PMID: 667423 PMC: 1668437.

REISBY N, Gram L, Bech P, Nagy A, Petersen G, Ortmann J Psychopharmacology (Berl). 1977; 54(3):263-72.

PMID: 413143 DOI: 10.1007/BF00426574.

Gram L Clin Pharmacokinet. 1977; 2(4):237-51.

PMID: 332426 DOI: 10.2165/00003088-197702040-00001.

Potter W, Muscettola G, Goodwin F Psychopharmacology (Berl). 1979; 63(2):187-92.

PMID: 112637 DOI: 10.1007/BF00429700.

Brinkschulte M, Breyer-Pfaff U Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(1):1-7.

PMID: 40137 DOI: 10.1007/BF00499712.